NCT02070705 2025-07-31
DCE MRI in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
Clinical Trials
9 trialsNCT00103038 2022-06-09
Ferumoxytol in Improving MR Imaging in Patients With High-Grade Brain Tumors or Cerebral Metastases
OHSU Knight Cancer Institute
Phase NA Completed
NCT02359097 2022-03-17
Steady State Blood Volume Maps Using Ferumoxytol Non-stoichiometric Magnetite MRI in Imaging Patients With Glioblastoma
OHSU Knight Cancer Institute
Phase NA Completed
NCT01663090 2020-10-19
Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas
Dana-Farber Cancer Institute
Phase NA Withdrawn
NCT01815333 2020-10-19
Clinical and Technical Feasibility of a Ultrasuperparamagnetic Nanoparticle Iron Oxide (USPIO)-Enhanced Magnetic Resonance Lymph Node Imaging
M.D. Anderson Cancer Center
Phase NA Completed
NCT02253602 2019-01-16
IMPROVE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT01927887 2017-06-06
Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study
Massachusetts General Hospital
Phase NA Completed
NCT00660543 2017-05-16
MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy
OHSU Knight Cancer Institute
Phase NA Completed
NCT01983371 2016-05-20
Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
University of Vermont
Phase NA Withdrawn